BACKGROUND: Sleeve lobectomy for lung cancer in close proximity to or involving the carina is widely accepted. Operative morbidity and mortality rates, recurrence, and survival rates have varied considerably across studies. MATERIALS AND METHODS: From March of 2005 to July of 2010, sleeve lobectomy was performed in 19 patients and pneumonectomy was performed in 20 patients. In this paper, the results of sleeve lobectomy and pneumonectomy for patients with lung cancer will be compared and evaluated. RESULTS: There were no postoperative complications in either group, but there was one mortality in the pneumonectomy group. There was better preservation of pulmonary function in the sleeve lobectomy group than the pneumonectomy group (p=0.066 in FVC, p=0.019 in FEV1). The 3-year survival rates were 46.7% in the sleeve lobectomy group and 54.5% in the pneumonectomy group (p=0.505). The 3-year disease-free survival rates were 38% in the sleeve lobectomy group and 45.8% in the pneumonectomy group (p=0.200). CONCLUSION: Sleeve lobectomy for lung cancer showed low mortality, low bronchial anastomotic complication rates, and good preservation of pulmonary function.
BACKGROUND: Sleeve lobectomy for lung cancer in close proximity to or involving the carina is widely accepted. Operative morbidity and mortality rates, recurrence, and survival rates have varied considerably across studies. MATERIALS AND METHODS: From March of 2005 to July of 2010, sleeve lobectomy was performed in 19 patients and pneumonectomy was performed in 20 patients. In this paper, the results of sleeve lobectomy and pneumonectomy for patients with lung cancer will be compared and evaluated. RESULTS: There were no postoperative complications in either group, but there was one mortality in the pneumonectomy group. There was better preservation of pulmonary function in the sleeve lobectomy group than the pneumonectomy group (p=0.066 in FVC, p=0.019 in FEV1). The 3-year survival rates were 46.7% in the sleeve lobectomy group and 54.5% in the pneumonectomy group (p=0.505). The 3-year disease-free survival rates were 38% in the sleeve lobectomy group and 45.8% in the pneumonectomy group (p=0.200). CONCLUSION: Sleeve lobectomy for lung cancer showed low mortality, low bronchial anastomotic complication rates, and good preservation of pulmonary function.
Authors: M Okada; H Yamagishi; S Satake; H Matsuoka; Y Miyamoto; M Yoshimura; N Tsubota Journal: J Thorac Cardiovasc Surg Date: 2000-04 Impact factor: 5.209
Authors: H C Suen; B F Meyers; T Guthrie; M S Pohl; S Sundaresan; C L Roper; J D Cooper; G A Patterson Journal: Ann Thorac Surg Date: 1999-06 Impact factor: 4.330
Authors: A Paul; D Marelli; H Shennib; M King; N S Wang; J A Wilson; D S Mulder; R C Chiu Journal: J Thorac Cardiovasc Surg Date: 1989-10 Impact factor: 5.209
Authors: H A Gaissert; D J Mathisen; A C Moncure; A D Hilgenberg; H C Grillo; J C Wain Journal: J Thorac Cardiovasc Surg Date: 1996-05 Impact factor: 5.209
Authors: P E Van Schil; A Brutel de la Rivière; P J Knaepen; H A van Swieten; J J Defauw; J M van den Bosch Journal: Ann Thorac Surg Date: 1991-11 Impact factor: 4.330